Issue Highlights Clinical Gastroenterology and Hepatology Charles J. Kahi Clinical Gastroenterology and Hepatology Volume 15, Issue 5, Pages 611-613 (May 2017) DOI: 10.1016/j.cgh.2017.03.010 Copyright © 2017 AGA Institute Terms and Conditions
Figure 1 Pooled incidence rate of colorectal cancer in patients with ulcerative colitis with low-grade dysplasia. Clinical Gastroenterology and Hepatology 2017 15, 611-613DOI: (10.1016/j.cgh.2017.03.010) Copyright © 2017 AGA Institute Terms and Conditions
Figure 2 Pooled incidence rate of advanced neoplasia (colorectal cancer or high-grade dysplasia) in patients with ulcerative colitis with low-grade dysplasia. Clinical Gastroenterology and Hepatology 2017 15, 611-613DOI: (10.1016/j.cgh.2017.03.010) Copyright © 2017 AGA Institute Terms and Conditions
Figure 3 Stool characteristics. (A) Percent of stools that were classified as normal did not differ between groups. (B) There were a lower percentage of stools classified as constipation in the placebo group. (C) There was a trend for a lower percentage of stools to be classified as diarrhea in the fiber group. Clinical Gastroenterology and Hepatology 2017 15, 611-613DOI: (10.1016/j.cgh.2017.03.010) Copyright © 2017 AGA Institute Terms and Conditions
Figure 4 The Hong Kong Liver Cancer staging scheme as proposed by Yau et al.16 EVM, extrahepatic vascular invasion or distant metastasis. Clinical Gastroenterology and Hepatology 2017 15, 611-613DOI: (10.1016/j.cgh.2017.03.010) Copyright © 2017 AGA Institute Terms and Conditions